Long-Term Epoprostenol Infusion Therapy Could Induce Hyperthyroidism in Patients With Idiopathic and Hereditary Pulmonary Arterial Hypertension

被引：0
|
作者：
Funasako, Moritoshi [1 ]
Miyaji, Katsumasa [1 ]
Sakuma, Masahito [1 ]
Takagi, Yaemi [1 ]
Kyotani, Shingo [1 ]
Nakanishi, Norifumi [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Cntr, Suita, Osaka, Japan
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Pulmonary hypertension; Thyroid hormones;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A19627
引用
收藏
页数：2
相关论文
共 50 条
  • [31] IgG4-related disease in pulmonary arterial hypertension on Long-term epoprostenol treatment
    Shirai, Yuichiro
    Tamura, Yuichi
    Yasuoka, Hidekata
    Satoh, Toru
    Kuwana, Masataka
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (05) : 1516 - 1519
  • [32] Long-Term Epoprostenol Therapy in Pulmonary Artery Hypertension - Sequence of Changes in Hemodynamic Effects
    Sakuma, Masahito
    Demachi, Jun
    Nawata, Jun
    Suzuki, Jun
    Takahashi, Tohru
    Shirato, Kunio
    CIRCULATION JOURNAL, 2009, 73 (03) : 523 - 529
  • [33] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [34] Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
    Oudiz, Ronald J.
    Galie, Nazzareno
    Olschewski, Horst
    Torres, Fernando
    Frost, Adaani
    Ghofrani, Hossein A.
    Badesch, David B.
    McGoon, Michael D.
    McLaughlin, Vallerie V.
    Roecker, Ellen B.
    Harrison, Brooke C.
    Despain, Darrin
    Dufton, Christopher
    Rubin, Lewis J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (21) : 1971 - 1981
  • [35] Marked Hemodynamic Improvements by High-Dose Epoprostenol Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
    Akagi, Satoshi
    Nakamura, Kazufumi
    Miyaji, Katsumasa
    Ogawa, Aiko
    Kusano, Kengo Fukushima
    Ito, Hiroshi
    Matsubara, Hiromi
    CIRCULATION JOURNAL, 2010, 74 (10) : 2200 - 2205
  • [36] Transition from IV Epoprostenol to Oral/Inhaled Targeted Pulmonary Arterial Hypertension Therapy In Pediatric Idiopathic Pulmonary Arterial Hypertension
    Melnick, L. E.
    Barst, R. J.
    Rowan, C. A.
    Kerstein, Diane
    Brady, D.
    Rosenzweig, E. B.
    CIRCULATION, 2008, 118 (18) : S877 - S877
  • [37] Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy
    Lars Knudsen
    Alexander Schurawlew
    Nils Nickel
    Henning Tiede
    Hossein A Ghofrani
    Heinrike Wilkens
    Ralf Ewert
    Michael Halank
    Hans Klose
    Carlos Bäzner
    Jürgen Behr
    Marius M Hoeper
    BMC Pulmonary Medicine, 11
  • [38] Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy
    Knudsen, Lars
    Schurawlew, Alexander
    Nickel, Nils
    Tiede, Henning
    Ghofrani, Hossein A.
    Wilkens, Heinrike
    Ewert, Ralf
    Halank, Michael
    Klose, Hans
    Baezner, Carlos
    Behr, Juergen
    Hoeper, Marius M.
    BMC PULMONARY MEDICINE, 2011, 11
  • [39] Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial (vol 149, pg 521, 2008)
    Simonneau, G.
    Rubin, L. J.
    Galie, N.
    Barst, R. J.
    Fleming, T. R.
    Frost, A. E.
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (06) : 435 - 435
  • [40] Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension
    Onen, Zeynep Pinar
    Yildiz, Onur Akkoca
    Gulbay, Banu Eris
    Karabiyikoglu, Gulseren
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2006, 54 (02): : 177 - 181
12345